person · Reporting owner

Mikan George Lawrence III

Disclosed activity across 4 companies

Tapewire entity: 13004
SEC CIK: 0001381037

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
AUTONATION, INC.AN · Entity 3730	Director	January 02, 2026	January 06, 2026
ELLINGTON INCOME OPPORTUNITIES FUNDEIOM · Entity 112529	Trustee	October 18, 2018	November 01, 2018
UNITEDHEALTH GROUP INCUNH · Entity 2809	EVP UHG & CEO, Optum	June 05, 2011	June 07, 2011

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AUTONATION, INC.

Report date January 02, 2026 · Filed January 06, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, par value $0.01 per shareSEC Table I · non-derivative	Direct	22,170	Reported balance After 2026-01-02 transaction · row 1 1 source row Row 1 · 2026-01-02 · Grant · Acquired 1,210 · Balance 22,170 F1: 2026 grant of 1,210 vested restricted stock units (the "RSUs") pursuant to the AutoNation, Inc. 2024 Non-Employee Director Equity Plan (the "2024 Director Plan"). The RSUs will settle in shares of common stock, par value $0.01 per share, of AutoNation, Inc. (the "Company") in accordance with the terms of the award, including any deferral election made by the reporting person, and the 2024 Director Plan. Settlement of the RSUs will be accelerated in certain circumstances as provided in the terms of the award and the 2024 Director Plan, including in the event the reporting person ceases to serve as a non-employee director of the Company.
Common Stock, par value $0.01 per shareSEC Table I · non-derivative	IndirectBy Trust	14,259	Reported balance Holding disclosure · report date 2026-01-02 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 14,259

Filing footnotes · ownership attribution and instrument terms

F1: 2026 grant of 1,210 vested restricted stock units (the "RSUs") pursuant to the AutoNation, Inc. 2024 Non-Employee Director Equity Plan (the "2024 Director Plan"). The RSUs will settle in shares of common stock, par value $0.01 per share, of AutoNation, Inc. (the "Company") in accordance with the terms of the award, including any deferral election made by the reporting person, and the 2024 Director Plan. Settlement of the RSUs will be accelerated in certain circumstances as provided in the terms of the award and the 2024 Director Plan, including in the event the reporting person ceases to serve as a non-employee director of the Company.

ELLINGTON INCOME OPPORTUNITIES FUND

Report date October 18, 2018 · Filed November 01, 2018

This filing explicitly reported no securities owned.

UNITEDHEALTH GROUP INC

Report date June 05, 2011 · Filed June 07, 2011

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	209,278.777	Reported balance After 2011-06-05 transaction · row 1 1 source row Row 1 · 2011-06-05 · Tax withholding · Disposed 3,892 · Balance 209,278.777
Common StockSEC Table I · non-derivative	Indirectby 401(k)	142.9422	Reported balance Holding disclosure · report date 2011-06-05 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 142.9422

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

NeueHealth, Inc.

Report date October 02, 2025 · Filed October 06, 2025

Section 16 reporting ended · disclosed 2025-10-06. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2025-10-02 transaction · row 1 1 source row Row 1 · 2025-10-02 · Disposition to issuer · Disposed 249,453 · Balance 0 F1: On October 2, 2025, NH Holdings 2025, Inc. ("Parent"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), dated as of December 23, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc. F2: Pursuant to the Rollover Agreement, dated as of September 17, 2025 (the "Rollover Agreement"), entered into by and among NH Holdings 2025 SPV, L.P. ("Holdings"), NH Holdings 2025, Inc., NH Holdings Acquisition 2025, Inc. and the Reporting Person, the Reporting Person contributed its shares of Issuer common stock, Series A Convertible Perpetual Preferred Stock ("Series A Preferred Stock") and Series B Convertible Perpetual Preferred Stock ("Series B Preferred Stock") to Holdings in exchange for Holdings common units, series A preferred units and series B preferred units on a one for one basis in accordance with the Rollover Agreement, and effective as of the effective time of the Merger (the "Effective Time").
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2025-10-02 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2025-10-02 · Disposition to issuer · Disposed 58,876 · Balance 0 F3: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1: On October 2, 2025, NH Holdings 2025, Inc. ("Parent"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), dated as of December 23, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc. F5: Each Issuer restricted stock unit ("RSU") outstanding immediately prior to the Effective Time was assumed and adjusted into a restricted stock unit with respect to a number of shares of common stock of Parent equal to the number of shares of Issuer common stock subject to such Issuer RSU and continued to be subject to the same terms and restrictions set forth in the Issuer equity plans and any applicable individual award agreement issued thereunder (including with respect to vesting). F4: The original grant of these restricted stock units vest in equal annual installments beginning on 3/6/23.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2025-10-02 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2025-10-02 · Disposition to issuer · Disposed 260,000 · Balance 0 F3: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1: On October 2, 2025, NH Holdings 2025, Inc. ("Parent"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), dated as of December 23, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc. F5: Each Issuer restricted stock unit ("RSU") outstanding immediately prior to the Effective Time was assumed and adjusted into a restricted stock unit with respect to a number of shares of common stock of Parent equal to the number of shares of Issuer common stock subject to such Issuer RSU and continued to be subject to the same terms and restrictions set forth in the Issuer equity plans and any applicable individual award agreement issued thereunder (including with respect to vesting). F6: The original grant of these restricted stock units vest in equal annual installments beginning on 3/11/24.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2025-10-02 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2025-10-02 · Disposition to issuer · Disposed 580,000 · Balance 0 F3: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1: On October 2, 2025, NH Holdings 2025, Inc. ("Parent"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), dated as of December 23, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc. F5: Each Issuer restricted stock unit ("RSU") outstanding immediately prior to the Effective Time was assumed and adjusted into a restricted stock unit with respect to a number of shares of common stock of Parent equal to the number of shares of Issuer common stock subject to such Issuer RSU and continued to be subject to the same terms and restrictions set forth in the Issuer equity plans and any applicable individual award agreement issued thereunder (including with respect to vesting). F7: All of these restricted stock units vest on 10/11/26.

Filing footnotes · ownership attribution and instrument terms

F1: On October 2, 2025, NH Holdings 2025, Inc. ("Parent"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), dated as of December 23, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc.

F2: Pursuant to the Rollover Agreement, dated as of September 17, 2025 (the "Rollover Agreement"), entered into by and among NH Holdings 2025 SPV, L.P. ("Holdings"), NH Holdings 2025, Inc., NH Holdings Acquisition 2025, Inc. and the Reporting Person, the Reporting Person contributed its shares of Issuer common stock, Series A Convertible Perpetual Preferred Stock ("Series A Preferred Stock") and Series B Convertible Perpetual Preferred Stock ("Series B Preferred Stock") to Holdings in exchange for Holdings common units, series A preferred units and series B preferred units on a one for one basis in accordance with the Rollover Agreement, and effective as of the effective time of the Merger (the "Effective Time").

F3: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4: The original grant of these restricted stock units vest in equal annual installments beginning on 3/6/23.

F5: Each Issuer restricted stock unit ("RSU") outstanding immediately prior to the Effective Time was assumed and adjusted into a restricted stock unit with respect to a number of shares of common stock of Parent equal to the number of shares of Issuer common stock subject to such Issuer RSU and continued to be subject to the same terms and restrictions set forth in the Issuer equity plans and any applicable individual award agreement issued thereunder (including with respect to vesting).

F6: The original grant of these restricted stock units vest in equal annual installments beginning on 3/11/24.

F7: All of these restricted stock units vest on 10/11/26.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
August 12, 2022 Filed Aug 16, 2022 21:53 UTC	AUTONATION, INC. AN · Entity 3730	Exercise / conversionStock Option (right to buy) · Derivative	5,000	$0.00 Strike: $48.80	$0.00	Disclosure SEC source: 0000350698-22-000111 · wf-form4_166068680007988.xml · derivative · entry 8 Mikan George Lawrence III · CIK 0001381037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 5,000 shares Expires 2023-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became exercisable in 25% annual increments on each of the first four anniversaries of June 1, 2013. Read SEC document
August 12, 2022 Filed Aug 16, 2022 21:53 UTC	AUTONATION, INC. AN · Entity 3730	Exercise / conversionStock Option (right to buy) · Derivative	5,000	$0.00 Strike: $47.25	$0.00	Disclosure SEC source: 0000350698-22-000111 · wf-form4_166068680007988.xml · derivative · entry 7 Mikan George Lawrence III · CIK 0001381037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 5,000 shares Expires 2023-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became exercisable in 25% annual increments on each of the first four anniversaries of June 1, 2013. Read SEC document
August 12, 2022 Filed Aug 16, 2022 21:53 UTC	AUTONATION, INC. AN · Entity 3730	Exercise / conversionStock Option (right to buy) · Derivative	5,000	$0.00 Strike: $46.22	$0.00	Disclosure SEC source: 0000350698-22-000111 · wf-form4_166068680007988.xml · derivative · entry 6 Mikan George Lawrence III · CIK 0001381037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 5,000 shares Expires 2023-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became exercisable in 25% annual increments on each of the first four anniversaries of June 1, 2013. Read SEC document
August 12, 2022 Filed Aug 16, 2022 21:53 UTC	AUTONATION, INC. AN · Entity 3730	SaleCommon Stock, par value $0.01 per share	15,000	$123.94	$1,859,164.50	Disclosure SEC source: 0000350698-22-000111 · wf-form4_166068680007988.xml · nonDerivative · entry 4 Mikan George Lawrence III · CIK 0001381037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,244 F1 · price: This transaction was executed in multiple trades at prices ranging from $123.772 to $124.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document
August 12, 2022 Filed Aug 16, 2022 21:53 UTC	AUTONATION, INC. AN · Entity 3730	Exercise / conversionCommon Stock, par value $0.01 per share	5,000	$48.80	$244,000.00	Disclosure SEC source: 0000350698-22-000111 · wf-form4_166068680007988.xml · nonDerivative · entry 3 Mikan George Lawrence III · CIK 0001381037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,244 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 12, 2022 Filed Aug 16, 2022 21:53 UTC	AUTONATION, INC. AN · Entity 3730	Exercise / conversionCommon Stock, par value $0.01 per share	5,000	$47.25	$236,250.00	Disclosure SEC source: 0000350698-22-000111 · wf-form4_166068680007988.xml · nonDerivative · entry 2 Mikan George Lawrence III · CIK 0001381037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,244 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 12, 2022 Filed Aug 16, 2022 21:53 UTC	AUTONATION, INC. AN · Entity 3730	Exercise / conversionCommon Stock, par value $0.01 per share	5,000	$46.22	$231,100.00	Disclosure SEC source: 0000350698-22-000111 · wf-form4_166068680007988.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,244 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 07, 2022 Filed Mar 10, 2022 00:01 UTC	NeueHealth, Inc. BHG · Entity 74308	GrantStock Options (Right to Buy) · Derivative	3,458,367	$0.00 Strike: $1.79	$0.00	Disclosure SEC source: 0001415889-22-002813 · form4-03092022_040337.xml · derivative · entry 2 Mikan George Lawrence III · CIK 0001381037 · Director · CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,458,367 Underlying: Common Stock · 3,458,367 shares Expires 2032-03-07 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on March 7, 2023. Read SEC document
March 07, 2022 Filed Mar 10, 2022 00:01 UTC	NeueHealth, Inc. BHG · Entity 74308	GrantRestricted Stock Units · Derivative	1,815,642	$0.00	$0.00	Disclosure SEC source: 0001415889-22-002813 · form4-03092022_040337.xml · derivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · Director · CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,815,642 Underlying: Common Stock · 1,815,642 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on March 7, 2023. F2 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning on March 7, 2023. Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:18 UTC	AUTONATION, INC. AN · Entity 3730	GrantCommon Stock, par value $0.01 per share	2,192	$0.00	$0.00	Disclosure SEC source: 0000350698-22-000015 · wf-form4_164141746741288.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,244 F1 · kind: 2022 grant of 2,192 vested restricted stock units (the "RSUs") pursuant to the AutoNation, Inc. 2014 Non-Employee Director Equity Plan (as amended, the "2014 Director Plan"). The RSUs will settle in shares of common stock, par value $0.01 per share, of AutoNation, Inc. (the "Company") in accordance with the terms of the award, including any deferral election made by the reporting person, and the 2014 Director Plan. Settlement of the RSUs will be accelerated in certain circumstances as provided in the terms of the award and the 2014 Director Plan, including in the event the reporting person ceases to serve as a non-employee director of the Company. Read SEC document
December 14, 2021 Filed Dec 17, 2021 00:17 UTC	NeueHealth, Inc. BHG · Entity 74308	GrantRestricted Stock Units · Derivative	7,000,000	$0.00	$0.00	Disclosure SEC source: 0001415889-21-006042 · form4-12162021_041237.xml · derivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · Director · CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000,000 Underlying: Common Stock · 7,000,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of BHG common stock. F2 · derivative.exercise_date: The restricted stock units vest 60% on the 2nd anniversary of the grant date and 40% on the 3rd anniversary of the grant date. F2 · derivative.expiration_date: The restricted stock units vest 60% on the 2nd anniversary of the grant date and 40% on the 3rd anniversary of the grant date. Read SEC document
July 28, 2021 Filed Jul 30, 2021 21:01 UTC	AUTONATION, INC. AN · Entity 3730	GiftCommon Stock, par value $0.01 per share	14,259	$0.00	$0.00	Disclosure SEC source: 0000350698-21-000126 · wf-form4_162767889704215.xml · nonDerivative · entry 2 Mikan George Lawrence III · CIK 0001381037 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 14,259 Read SEC document
July 28, 2021 Filed Jul 30, 2021 21:01 UTC	AUTONATION, INC. AN · Entity 3730	GiftCommon Stock, par value $0.01 per share	14,259	$0.00	$0.00	Disclosure SEC source: 0000350698-21-000126 · wf-form4_162767889704215.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,052 Read SEC document
June 28, 2021 Filed Jul 1, 2021 01:23 UTC	NeueHealth, Inc. BHG · Entity 74308	GrantRestricted Stock Units · Derivative	7,350,000	$0.00	$0.00	Disclosure SEC source: 0001104659-21-087820 · tm2121142-1_4seq1.xml · derivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,350,000 Underlying: Common Stock · 7,350,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock ("Common Stock"). F2 · derivative.exercise_date: These performance-based restricted stock units ("PSUs") shall vest if the performance conditions described below are met as follows: if (a) a price per share goal described below is achieved before the third anniversary of the date of grant (June 28, 2024), the corresponding PSUs shall remain unvested and require the Reporting Person to remain employed through such third anniversary date, and (b) a price per share goal described below is achieved after such third anniversary date, the corresponding PSUs shall vest upon the achievement of such price per share goal. F3 · derivative.exercise_date: These PSUs shall vest as follows if the following price per share goals are met prior to the fifth anniversary of the date of grant (June 28, 2026): (a) 25% of the PSUs shall vest if the average closing stock price per share of the Common Stock measured over 30 consecutive trading days (the "Average Price") exceeds $27.00, (b) 25% of the PSUs shall vest if the Average Price exceeds $36.00, (c) 25% of the PSUs shall vest if the Average Price exceeds $45.00, and (d) 25% of the PSUs shall vest if the Average Price exceeds $54.00. If any such price per share goal stated above is not achieved by the fifth anniversary of the grant, the corresponding PSUs shall be forfeited. F2 · derivative.expiration_date: These performance-based restricted stock units ("PSUs") shall vest if the performance conditions described below are met as follows: if (a) a price per share goal described below is achieved before the third anniversary of the date of grant (June 28, 2024), the corresponding PSUs shall remain unvested and require the Reporting Person to remain employed through such third anniversary date, and (b) a price per share goal described below is achieved after such third anniversary date, the corresponding PSUs shall vest upon the achievement of such price per share goal. F3 · derivative.expiration_date: These PSUs shall vest as follows if the following price per share goals are met prior to the fifth anniversary of the date of grant (June 28, 2026): (a) 25% of the PSUs shall vest if the average closing stock price per share of the Common Stock measured over 30 consecutive trading days (the "Average Price") exceeds $27.00, (b) 25% of the PSUs shall vest if the Average Price exceeds $36.00, (c) 25% of the PSUs shall vest if the Average Price exceeds $45.00, and (d) 25% of the PSUs shall vest if the Average Price exceeds $54.00. If any such price per share goal stated above is not achieved by the fifth anniversary of the grant, the corresponding PSUs shall be forfeited. Read SEC document
May 11, 2021 Filed Jul 1, 2021 01:23 UTC	NeueHealth, Inc. BHG · Entity 74308	GiftStock Options (Right to Buy) · Derivative	3,600,000	$0.00 Strike: $1.04	$0.00	Disclosure SEC source: 0001104659-21-087820 · tm2121142-1_4seq1.xml · derivative · entry 5 Mikan George Lawrence III · CIK 0001381037 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By Mikan Family Enterprise, LLC Disclosed balance after: 3,600,000 Underlying: Common Stock · 3,600,000 shares Expires 2029-01-23 F4 · derivative.exercise_date: These stock options are fully vested. Read SEC document
May 11, 2021 Filed Jul 1, 2021 01:23 UTC	NeueHealth, Inc. BHG · Entity 74308	GiftStock Options (Right to Buy) · Derivative	3,600,000	$0.00 Strike: $1.04	$0.00	Disclosure SEC source: 0001104659-21-087820 · tm2121142-1_4seq1.xml · derivative · entry 4 Mikan George Lawrence III · CIK 0001381037 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 0 Underlying: Common Stock · 3,600,000 shares Expires 2029-01-23 F4 · derivative.exercise_date: These stock options are fully vested. Read SEC document
March 31, 2021 Filed Jul 1, 2021 01:23 UTC	NeueHealth, Inc. BHG · Entity 74308	GiftStock Options (Right to Buy) · Derivative	3,600,000	$0.00 Strike: $1.04	$0.00	Disclosure SEC source: 0001104659-21-087820 · tm2121142-1_4seq1.xml · derivative · entry 3 Mikan George Lawrence III · CIK 0001381037 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 3,600,000 Underlying: Common Stock · 3,600,000 shares Expires 2029-01-23 F4 · derivative.exercise_date: These stock options are fully vested. Read SEC document
March 31, 2021 Filed Jul 1, 2021 01:23 UTC	NeueHealth, Inc. BHG · Entity 74308	GiftStock Options (Right to Buy) · Derivative	3,600,000	$0.00 Strike: $1.04	$0.00	Disclosure SEC source: 0001104659-21-087820 · tm2121142-1_4seq1.xml · derivative · entry 2 Mikan George Lawrence III · CIK 0001381037 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,695,000 Underlying: Common Stock · 3,600,000 shares Expires 2029-01-23 F4 · derivative.exercise_date: These stock options are fully vested. Read SEC document
January 04, 2021 Filed Jan 6, 2021 21:05 UTC	AUTONATION, INC. AN · Entity 3730	GrantCommon Stock, par value $0.01 per share	3,671	$0.00	$0.00	Disclosure SEC source: 0000350698-21-000017 · wf-form4_160996710299758.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,311 F1 · kind: 2021 grant of 3,671 vested restricted stock units (the "RSUs") pursuant to the AutoNation, Inc. 2014 Non-Employee Director Equity Plan (as amended, the "2014 Director Plan"). The RSUs will settle in shares of common stock, par value $0.01 per share, of AutoNation, Inc. (the "Company") in accordance with the terms of the award, including any deferral election made by the reporting person, and the 2014 Director Plan. Settlement of the RSUs will be accelerated in certain circumstances as provided in the terms of the award and the 2014 Director Plan, including in the event the reporting person ceases to serve as a non-employee director of the Company. Read SEC document
January 02, 2020 Filed Jan 6, 2020 22:48 UTC	AUTONATION, INC. AN · Entity 3730	GrantCommon Stock, par value $0.01 per share	5,110	$0.00	$0.00	Disclosure SEC source: 0000350698-20-000013 · wf-form4_157835087537294.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,640 F1 · kind: 2020 grant of 5,110 vested restricted stock units (the "RSUs") pursuant to the AutoNation, Inc. 2014 Non-Employee Director Equity Plan (as amended, the "2014 Director Plan"). The RSUs will settle in shares of common stock, par value $0.01 per share, of AutoNation, Inc. (the "Company") in accordance with the terms of the award, including any deferral election made by the reporting person, and the 2014 Director Plan. Settlement of the RSUs will be accelerated in certain circumstances as provided in the terms of the award and the 2014 Director Plan, including in the event the reporting person ceases to serve as a non-employee director of the Company. Read SEC document
January 02, 2019 Filed Jan 4, 2019 22:34 UTC	AUTONATION, INC. AN · Entity 3730	GrantCommon Stock, par value $0.01 per share	6,934	$0.00	$0.00	Disclosure SEC source: 0000350698-19-000014 · wf-form4_154664126108354.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,530 F1 · kind: 2019 grant of 6,934 vested restricted stock units (the "RSUs") pursuant to the AutoNation, Inc. 2014 Non-Employee Director Equity Plan (as amended, the "2014 Director Plan"). The RSUs will settle in shares of common stock, par value $0.01 per share, of AutoNation, Inc. (the "Company") in accordance with the terms of the award, including any deferral election made by the reporting person, and the 2014 Director Plan. Settlement of the RSUs will be accelerated in certain circumstances as provided in the terms of the award and the 2014 Director Plan, including in the event the reporting person ceases to serve as a non-employee director of the Company. Read SEC document
January 02, 2018 Filed Jan 4, 2018 22:41 UTC	AUTONATION, INC. AN · Entity 3730	GrantCommon Stock, par value $0.01 per share	4,764	$0.00	$0.00	Disclosure SEC source: 0000350698-18-000017 · wf-form4_151510566369583.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,596 F1 · kind: 2018 grant of 4,764 vested restricted stock units (the "RSUs") pursuant to the AutoNation, Inc. 2014 Non-Employee Director Equity Plan (as amended, the "2014 Director Plan"). The RSUs will settle in shares of common stock, par value $0.01 per share, of AutoNation, Inc. (the "Company") in accordance with the terms of the award, including any deferral election made by the reporting person, and the 2014 Director Plan. Settlement of the RSUs will be accelerated in certain circumstances as provided in the terms of the award and the 2014 Director Plan, including in the event the reporting person ceases to serve as a non-employee director of the Company. Read SEC document
January 03, 2017 Filed Jan 5, 2017 22:45 UTC	AUTONATION, INC. AN · Entity 3730	GrantCommon Stock, par value $0.01 per share	5,073	$0.00	$0.00	Disclosure SEC source: 0000350698-17-000017 · wf-form4_148365634484011.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,832 F1 · kind: 2017 grant of 5,073 vested restricted stock units (the "RSUs") pursuant to the AutoNation, Inc. 2014 Non-Employee Director Equity Plan (the "2014 Director Plan"). The RSUs will settle in shares of common stock, par value $0.01 per share, of AutoNation, Inc. (the "Company") in accordance with the terms of the award, including any deferral election made by the reporting person, and the 2014 Director Plan. Settlement of the RSUs will be accelerated in certain circumstances as provided in the terms of the award and the 2014 Director Plan, including in the event the reporting person ceases to serve as a non-employee director of the Company. Read SEC document
June 05, 2011 Filed Jun 7, 2011 21:32 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	Tax withholdingCommon Stock	3,892	$48.85	$190,124.20	Disclosure SEC source: 0001209191-11-033549 · doc4.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · EVP UHG & CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,278.777 Read SEC document
May 02, 2011 Filed May 3, 2011 20:35 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	Exercise / conversionNon-qualified stock option (right to buy) · Derivative	52,500	$0.00 Strike: $28.10	$0.00	Disclosure SEC source: 0001209191-11-025685 · doc4.xml · derivative · entry 8 Mikan George Lawrence III · CIK 0001381037 · EVP UHG & CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 52,500 shares Expires 2013-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 02, 2011 Filed May 3, 2011 20:35 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	Exercise / conversionNon-qualified stock option (right to buy) · Derivative	17,500	$0.00 Strike: $26.18	$0.00	Disclosure SEC source: 0001209191-11-025685 · doc4.xml · derivative · entry 7 Mikan George Lawrence III · CIK 0001381037 · EVP UHG & CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 17,500 shares Expires 2013-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 02, 2011 Filed May 3, 2011 20:35 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	Exercise / conversionNon-qualified stock option (right to buy) · Derivative	75,000	$0.00 Strike: $20.73	$0.00	Disclosure SEC source: 0001209191-11-025685 · doc4.xml · derivative · entry 6 Mikan George Lawrence III · CIK 0001381037 · EVP UHG & CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 75,000 shares Expires 2013-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 02, 2011 Filed May 3, 2011 20:35 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	SaleCommon Stock	145,000	$49.39	$7,160,912.00	Disclosure SEC source: 0001209191-11-025685 · doc4.xml · nonDerivative · entry 4 Mikan George Lawrence III · CIK 0001381037 · EVP UHG & CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,170.777 F1 · price: This transaction was executed in multiple trades ranging from $49.25 to $49.51 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document
May 02, 2011 Filed May 3, 2011 20:35 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	Exercise / conversionCommon Stock	52,500	$28.10	$1,475,250.00	Disclosure SEC source: 0001209191-11-025685 · doc4.xml · nonDerivative · entry 3 Mikan George Lawrence III · CIK 0001381037 · EVP UHG & CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,170.777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 02, 2011 Filed May 3, 2011 20:35 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	Exercise / conversionCommon Stock	17,500	$26.18	$458,062.50	Disclosure SEC source: 0001209191-11-025685 · doc4.xml · nonDerivative · entry 2 Mikan George Lawrence III · CIK 0001381037 · EVP UHG & CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,670.777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 02, 2011 Filed May 3, 2011 20:35 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	Exercise / conversionCommon Stock	75,000	$20.73	$1,554,375.00	Disclosure SEC source: 0001209191-11-025685 · doc4.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · EVP UHG & CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,170.777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 21, 2011 Filed Mar 22, 2011 22:31 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	GrantCommon Stock	326.777	$0.00	$0.00	Disclosure SEC source: 0001209191-11-019262 · doc4.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · EVP UHG & CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,170.777 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document
February 09, 2011 Filed Feb 11, 2011 21:27 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	GrantCommon Stock	59,425	$0.00	$0.00	Disclosure SEC source: 0001209191-11-008861 · doc4.xml · nonDerivative · entry 3 Mikan George Lawrence III · CIK 0001381037 · EVP UHG & CEO, Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,844 F2 · shares: The restricted stock units will vest 100% on the fourth anniversary of the grant date. F3 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2011, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 53,483. Read SEC document
February 09, 2011 Filed Feb 11, 2011 21:27 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	GrantCommon Stock	53,483	$0.00	$0.00	Disclosure SEC source: 0001209191-11-008861 · doc4.xml · nonDerivative · entry 2 Mikan George Lawrence III · CIK 0001381037 · EVP UHG & CEO, Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,419 F1 · shares: The restricted stock units will vest at a rate of 33% on February 9, 2012; December 28, 2012; and February 9, 2014. Read SEC document
February 09, 2011 Filed Feb 11, 2011 21:27 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	Tax withholdingCommon Stock	2,478	$42.07	$104,249.46	Disclosure SEC source: 0001209191-11-008861 · doc4.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · EVP UHG & CEO, Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,936 Read SEC document
February 03, 2011 Filed Feb 4, 2011 23:53 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	Tax withholdingCommon Stock	3,168	$43.04	$136,350.72	Disclosure SEC source: 0001209191-11-007317 · doc4.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,414 F1 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document
December 17, 2010 Filed Dec 20, 2010 22:01 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	Exercise / conversionNon-qualified stock option (right to buy) · Derivative	25,000	$0.00 Strike: $20.06	$0.00	Disclosure SEC source: 0001209191-10-061687 · doc4.xml · derivative · entry 4 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common stock · 25,000 shares Expires 2013-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 17, 2010 Filed Dec 20, 2010 22:01 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	SaleCommon Stock	25,000	$35.26	$881,375.00	Disclosure SEC source: 0001209191-10-061687 · doc4.xml · nonDerivative · entry 2 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,335 F2 · price: This transaction was executed in multiple trades ranging from $35.20 to $35.345 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Includes shares and dividend shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document
December 17, 2010 Filed Dec 20, 2010 22:01 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	Exercise / conversionCommon Stock	25,000	$20.06	$501,500.00	Disclosure SEC source: 0001209191-10-061687 · doc4.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares and dividend shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document
June 05, 2010 Filed Jun 8, 2010 21:33 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	Tax withholdingCommon Stock	3,891	$30.34	$118,052.94	Disclosure SEC source: 0000731766-10-000071 · edgardoc.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,734 F1 · balance_after: Includes dividend shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document
February 09, 2010 Filed Feb 11, 2010 23:49 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	GrantStock Appreciation Rights · Derivative	76,024	$0.00 Strike: $33.00	$0.00	Disclosure SEC source: 0000731766-10-000026 · edgardoc.xml · derivative · entry 3 Mikan George Lawrence III · CIK 0001381037 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,024 Underlying: Common Stock · 76,024 shares Expires 2020-02-09 F3 · derivative.exercise_date: The stock appreciation rights will vest at a rate of 25% annually on February 9 from the years 2011 through 2014. Read SEC document
February 09, 2010 Filed Feb 11, 2010 23:49 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	GrantCommon Stock	30,304	$0.00	$0.00	Disclosure SEC source: 0000731766-10-000026 · edgardoc.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,623 F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 9 from the years 2011 through 2014. F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2010, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 60,607. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document
February 03, 2010 Filed Feb 5, 2010 23:22 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	Tax withholdingCommon Stock	3,144	$33.32	$104,758.08	Disclosure SEC source: 0000731766-10-000013 · edgardoc.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,319 F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document
December 10, 2009 Filed Dec 10, 2009 22:36 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative	30,000	$0.00 Strike: $22.11	$0.00	Disclosure SEC source: 0000731766-09-000096 · edgardoc.xml · derivative · entry 8 Mikan George Lawrence III · CIK 0001381037 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2012-08-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 10, 2009 Filed Dec 10, 2009 22:36 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative	30,000	$0.00 Strike: $20.54	$0.00	Disclosure SEC source: 0000731766-09-000096 · edgardoc.xml · derivative · entry 7 Mikan George Lawrence III · CIK 0001381037 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2012-08-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 10, 2009 Filed Dec 10, 2009 22:36 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative	25,000	$0.00 Strike: $18.13	$0.00	Disclosure SEC source: 0000731766-09-000096 · edgardoc.xml · derivative · entry 6 Mikan George Lawrence III · CIK 0001381037 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2012-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 10, 2009 Filed Dec 10, 2009 22:36 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	SaleCommon Stock	85,000	$30.00	$2,550,000.00	Disclosure SEC source: 0000731766-09-000096 · edgardoc.xml · nonDerivative · entry 4 Mikan George Lawrence III · CIK 0001381037 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,172 F1 · price: This transaction was executed in multiple trades, each of which was at the price of $30.00 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares in each transaction effected. Read SEC document
December 10, 2009 Filed Dec 10, 2009 22:36 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	Exercise / conversionCommon Stock	30,000	$20.54	$616,050.00	Disclosure SEC source: 0000731766-09-000096 · edgardoc.xml · nonDerivative · entry 3 Mikan George Lawrence III · CIK 0001381037 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 10, 2009 Filed Dec 10, 2009 22:36 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	Exercise / conversionCommon Stock	30,000	$22.11	$663,300.00	Disclosure SEC source: 0000731766-09-000096 · edgardoc.xml · nonDerivative · entry 2 Mikan George Lawrence III · CIK 0001381037 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 10, 2009 Filed Dec 10, 2009 22:36 UTC	UNITEDHEALTH GROUP INC UNH · Entity 2809	Exercise / conversionCommon Stock	25,000	$18.13	$453,137.50	Disclosure SEC source: 0000731766-09-000096 · edgardoc.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.